Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen (HBsAg)

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions

Hepatitis B

Interventions

PROCEDURE

Blood sampling

A blood sample will be taken yearly at each long-term follow-up time point (i.e. Year 16 through Year 20) after the first dose of Engerix-B™ vaccine.

Trial Locations (1)

GSK Investigational Site, Bangkok